Beyond T-cells: New Mechanisms in the Pathogenesis of MS
Presented by The Johns Hopkins University School of Medicine The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Supported through an educational grant from Genentech, Inc., and Biogen Idec. Release date: June 30th 2007 Expiration date: June 30th 2008 Estimated time to complete activity: 1 hour The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity
This program will explore the role of B-cells in the pathogenesis of MS, including the clinical effects of B-cell depletion. The potential impact of new findings regarding pathogenesis on research aimed at finding new therapies for MS will also be discussed by an expert panel. Dr. Peter Calabresi (Program Chair) has received grants, research support, honorarium and/or has consulted for Amgen Inc., Genentech, Inc., Novartis, Teva Neuroscience, Serono, Inc., and Vertex Pharmaceuticals Inc. Dr. Bruce Anthony Campbell Cree has no relevant conflict of interest to disclose. Dr. Samia Khoury has no relevant conflict of interest to disclose. *The "T-Cells" image used in this program was provided by © F. Hoffmann- La Roche Ltd, Basel, Switzerland. © 2007 the Johns Hopkins University School of Medicine. All rights reserved. Click here to review the complete CME information.

http://www.msleaders.org/ms-leaders/cme/beyond-t-cells.asp?